Search
forResearch 10 of 658
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Alopecia Areata: An Evidence-Based Treatment Update
- Madarosis
- Hapten‐induced lymphadenosis benigna cutis secondary to squaric acid dibutylester sensitization for alopecia areata
- Polycystic ovary syndrome: A review for dermatologists
- New developments in our understanding of acne pathogenesis and treatment
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Polycystic Ovarian Syndrome
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →